4
Changes in Ownership
Jade Biosciences, Inc. Filed Acc 0001415889-23-015986
Dake Benjamin T sold 10,283 shares at $16.11 ($165,628)
- Dake Benjamin T acquired 10,283 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-06 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,411 | $1.74 | $4,195 | 3,702 | D |
| 2023-12-06 | Exercise or conversion : show line 2 in the form 10b5-1 | +7,872 | $2.14 | $16,846 | 11,574 | D |
| 2023-12-06 | Sale : show line 3 in the form 10b5-1 | −10,283 | $16.11 | $165,628 | 1,291 | D |
| Open-market sales · 10,283 sh · avg $16.11 · $165,628 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-12-06 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) | −905 | 906 | D |
| 2023-12-06 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) | −1,506 | 12,055 | D |
| 2023-12-06 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) | −1,019 | 16,294 | D |
| 2023-12-06 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) | −6,853 | 123,346 | D |
Loading xslF345X05/form4-12072023_061201.xml…